Your Client Rank:
Loading...
99
Updated 21-Nov-2024
| Company | Sales | Gross M. | SGA % Sales | R&D % Sales | Trading M. | Tax Rate | Net Income | EPS |
| | | | | | | | |
| Lilly | 22.2% | 0.8% | -8.7% | -13.4% | 19.7% | -6.0% | 47.7% | 47.7% |
| Novo | 17.0% | -0.1% | -2.7% | 0.3% | 1.6% | 0.4% | 17.9% | 19.1% |
| Daiichi | 13.5% | 2.6% | 1.5% | -2.8% | 11.1% | 6.1% | 21.9% | 22.4% |
| Vertex | 9.7% | 0.4% | 2.0% | -6.8% | 2.7% | 1.3% | 12.6% | 11.8% |
| Astra | 8.5% | 0.1% | -3.5% | -1.0% | 3.9% | 3.4% | 11.2% | 11.4% |
| Eisai | 8.0% | -0.6% | -2.0% | -5.0% | 13.9% | -7.9% | 23.7% | 23.7% |
| Regeneron | 7.3% | 0.2% | -0.8% | 0.2% | 2.5% | 14.2% | 9.0% | 9.1% |
| AbbVie | 6.1% | 0.2% | -3.0% | -2.1% | 2.0% | 1.6% | 8.5% | 8.6% |
| Sanofi | 5.8% | 1.0% | -4.0% | -1.8% | 4.9% | 2.1% | 7.0% | 7.4% |
| Merck | 5.6% | 1.3% | -3.1% | -17.0% | 35.2% | -15.5% | 52.4% | 53.3% |
| Amgen | 5.1% | -0.3% | 0.1% | 1.5% | -0.4% | -1.4% | 4.4% | 4.6% |
| JnJ | 3.9% | -0.1% | -0.7% | -0.7% | 0.9% | 2.8% | 3.5% | 4.9% |
| Novartis | 3.9% | 0.0% | -2.9% | -0.3% | 3.4% | 1.6% | 7.0% | 7.8% |
| Chugai | 3.9% | 3.6% | 0.4% | -0.6% | 3.3% | 0.3% | 7.0% | 7.0% |
| Roche | 3.6% | 0.3% | -1.9% | -1.7% | 2.6% | 9.1% | 5.4% | 5.0% |
| Teva | 3.3% | 1.1% | | | 2.0% | 4.2% | 7.1% | 6.3% |
| Lundbeck | 3.2% | 1.2% | -2.2% | 3.6% | 4.4% | -0.7% | 9.9% | 4.1% |
| Gilead | 2.8% | -0.1% | -2.4% | -3.8% | 3.2% | 6.8% | 4.7% | 4.9% |
| Glaxo | 2.7% | 0.0% | -0.5% | 1.2% | 4.6% | 2.9% | 6.5% | 4.0% |
| Takeda | 2.1% | 0.6% | -0.5% | 0.0% | 22.6% | | 3.7% | 3.5% |
| Astellas | 1.6% | -0.8% | -6.2% | 1.2% | 14.1% | 4.9% | 13.9% | 14.7% |
| Shionogi | 1.2% | -0.4% | -2.4% | 2.4% | -0.1% | 1.4% | 0.1% | 1.1% |
| Pfizer | 1.1% | 4.7% | -2.1% | 0.0% | 15.5% | 11.2% | 10.1% | 8.9% |
| Bayer | 0.7% | 0.8% | 0.8% | 3.4% | 1.2% | | -2.4% | -1.6% |
| Biogen | 0.3% | 1.4% | -0.2% | -2.6% | 5.5% | 1.5% | 6.2% | 6.3% |
| Bristol | -1.7% | -0.4% | 1.5% | -0.3% | -1.0% | 3.4% | -5.4% | -4.4% |
| Neurocrine | | | | | | | | |
| EU Major | 5.9% | 0.6% | -2.2% | -0.5% | 4.0% | 1.3% | 8.6% | 6.9% |
| Other EU | 3.2% | 1.2% | -2.2% | 3.6% | 4.4% | -0.7% | 9.9% | 4.1% |
| US Major | 6.0% | 1.2% | -2.9% | -7.1% | 9.2% | 0.0% | 14.7% | 20.1% |
| US Big Biotech | 4.8% | 0.2% | -1.3% | -1.8% | 2.1% | 3.0% | 6.7% | 8.1% |
| Other US | 3.3% | 1.1% | | | 2.0% | 4.2% | 7.1% | 6.3% |
| Japanese | 4.9% | 1.1% | -0.8% | -0.5% | 10.7% | 11.7% | 8.6% | 9.9% |
